Fiera Capital (Canada)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,380
Closed -$212K 586
2022
Q2
$212K Hold
6,380
﹤0.01% 568
2022
Q1
$460K Hold
6,380
﹤0.01% 529
2021
Q4
$586K Hold
6,380
﹤0.01% 501
2021
Q3
$809K Hold
6,380
﹤0.01% 393
2021
Q2
$1.06M Hold
6,380
﹤0.01% 408
2021
Q1
$1.16M Sell
6,380
-32,000
-83% -$7.42M ﹤0.01% 378
2020
Q4
$7.67M Sell
38,380
-117,735
-75% -$23.9M 0.02% 207
2020
Q3
$34.2M Sell
156,115
-4,274
-3% -$905K 0.1% 121
2020
Q2
$30.6M Sell
160,389
-191,862
-54% -$33.6M 0.1% 116
2020
Q1
$54.6M Sell
352,251
-96,418
-21% -$11.2M 0.23% 61
2019
Q4
$37.6M Sell
448,669
-31,603
-7% -$2.4M 0.13% 113
2019
Q3
$32.5M Buy
480,272
+5,187
+1% +$341K 0.12% 124
2019
Q2
$31.6M Buy
475,085
+265,941
+127% +$15.5M 0.12% 136
2019
Q1
$11.6M Sell
209,144
-5,288
-2% -$323K 0.05% 201
2018
Q4
$10.6M Buy
+214,432
New +$13.1M 0.05% 204

Other funds holding TDOC

Fiera Capital (Canada)'s TDOC Position: Q3 2022 in Review

Fiera Capital (Canada) sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 6,380 shares — an estimated $212K sold.

Fiera Capital (Canada) first reported a position in TDOC in Q4 2018 and held it in 15 quarters. The position peaked at $54.6M in Q1 2020. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Fiera Capital (Canada) reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Fiera Capital (Canada) sold 6,380 Teladoc Health shares in Q3 2022, an estimated $212K.
  • Fiera Capital (Canada) first reported a position in Teladoc Health in Q4 2018 and held it in 15 quarters.
  • Fiera Capital (Canada)'s Teladoc Health position peaked at $54.6M in Q1 2020.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2022, filed 3 Nov 2022.